Your browser doesn't support javascript.
loading
Using Routinely Collected Electronic Healthcare Record Data to Investigate Fibrotic Multimorbidity in England.
Massen, Georgie M; Whittaker, Hannah R; Cook, Sarah; Jenkins, Gisli; Allen, Richard J; Wain, Louise V; Stewart, Iain; Quint, Jennifer K.
Afiliación
  • Massen GM; School of Public Health, Imperial College London, London, UK.
  • Whittaker HR; School of Public Health, Imperial College London, London, UK.
  • Cook S; School of Public Health, Imperial College London, London, UK.
  • Jenkins G; National Heart and Lung Institute, Imperial College London, London, UK.
  • Allen RJ; Department of Population Health Sciences, University of Leicester, Leicester, UK.
  • Wain LV; NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK.
  • Stewart I; Department of Population Health Sciences, University of Leicester, Leicester, UK.
  • Quint JK; NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK.
Clin Epidemiol ; 16: 433-443, 2024.
Article en En | MEDLINE | ID: mdl-38952572
ABSTRACT

Background:

Electronic healthcare records (EHRs) are used to document diagnoses, symptoms, tests, and prescriptions. Though not primarily collected for research purposes, owing to the size of the data as well as the depth of information collected, they have been used extensively to conduct epidemiological research. The Clinical Practice Research Datalink (CPRD) is an EHR database containing representative data of the UK population with regard to age, sex, race, and social deprivation measures. Fibrotic conditions are characterised by excessive scarring, contributing towards organ dysfunction and eventual organ failure. Fibrosis is associated with ageing as well as many other factors, it is hypothesised that fibrotic conditions are caused by the same underlying pathological mechanism. We calculated the prevalence of fibrotic conditions (as defined in a previous Delphi survey of clinicians) as well as the prevalence of fibrotic multimorbidity (the proportion of people with multiple fibrotic conditions).

Methods:

We included a random sample of 993,370 UK adults, alive, and enrolled at a UK general practice, providing data to the CPRD Aurum database as of 1st of January 2015. Individuals had to be eligible for linkage to hospital episode statistics (HES) and ONS death registration. We calculated the point prevalence of fibrotic conditions and multi-morbid fibrosis on the 1st of January 2015. Using death records of those who died in 2015, we investigated the prevalence of fibrosis associated death. We explored the most commonly co-occurring fibrotic conditions and determined the settings in which diagnoses were commonly made (primary care, secondary care or after death).

Results:

The point prevalence of any fibrotic condition was 21.46%. In total, 6.00% of people had fibrotic multimorbidity. Of the people who died in 2015, 34.82% had a recording of a fibrotic condition listed on their death certificate.

Conclusion:

The key finding was that fibrotic multimorbidity affects approximately 1 in 16 people.
Fibrotic conditions are scarring conditions which impact the way an organ functions and eventually lead to organ failure. We studied routinely collected health data from GPs, hospitals, and death certificates to estimate the percentage of UK adults who had fibrotic diseases. We found that 1 in 5 people had at least one fibrotic disease, and we also found that 1 in 16 people had more than one fibrotic disease.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Clin Epidemiol Año: 2024 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Nueva Zelanda

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Clin Epidemiol Año: 2024 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Nueva Zelanda